Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation

January 11, 2023 updated by: Sofia Straudi, University Hospital of Ferrara

Recovery Profiles in Patients With COVID-19 Outcomes Undergoing Rehabilitation

COVID19 patients survivors, after discharge from hospital show reduced lung function and reduced ability to exercise. Furthermore, mental health problems including stress, anxiety and depression and a low quality of life were observed. The prospective observational study involves COVID19 patients who have needed rehabilitation at the University Hospital of Ferrara. Patients receive comprehensive rehabilitation based on their specific needs in both acute and subacute rehabilitation. At the end of hospital rehabilitation, patients are offered a program to be carried out at home for both physical and psychological problems. A range of demographic and clinical data will be collected. Patients will also undergo a battery of functional, cognitive and psychological tests at 12, 26 and 52 weeks from the infection onset. Moreover, a specific assessement (both clinical and instrumental) on the pain symptom experienced, where present, will be done.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Emilia Romagna
      • Ferrara, Emilia Romagna, Italy, 44124
        • Recruiting
        • Department of Neuroscience and Rehabilitation, University Hospital of Ferrara
        • Contact:
        • Principal Investigator:
          • Sofia Straudi, MD, PhD
        • Sub-Investigator:
          • Anna Scotti, MD
        • Sub-Investigator:
          • Nicola Lamberti, PhD
        • Sub-Investigator:
          • Francesco Baldasso, MD
        • Sub-Investigator:
          • Antonella Occhi, PT
        • Sub-Investigator:
          • Silvia Mottaran, PT
        • Sub-Investigator:
          • Ilaria Ferioli, PT
        • Sub-Investigator:
          • Fabio Manfredini, MD, PhD
        • Sub-Investigator:
          • Giada Milani, PsyD, PhD student
        • Sub-Investigator:
          • Giulia Dallagà, PsyD
        • Sub-Investigator:
          • Susanna Lavezzi, MD
        • Sub-Investigator:
          • Francesca Filippini, PT
        • Sub-Investigator:
          • Giulia Bellon, MD
        • Sub-Investigator:
          • Alessandra Botti, MD
        • Sub-Investigator:
          • Elisabetta Antiga, MD
        • Sub-Investigator:
          • Dino De Filippo, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

People infected with COVID-19 and healthy subjects matched for age and sex (pain assessment).

Description

Inclusion Criteria:

  • diagnosis of covid19 (WHO criteria);
  • indication for respiratory and / or neuromotor rehabilitation treatment

Exclusion Criteria:

  • cognitive or communication impairment precluding informed consent
  • severe medical conditions
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Borg scale
Time Frame: At the beginning of early rehabilitation
Rating perceived exertion on a 10-points scale in which higher values correspond to havier symptomps.
At the beginning of early rehabilitation
Heart rate
Time Frame: At the beginning of early rehabilitation
Heart rate in sitting and standing positions.
At the beginning of early rehabilitation
Oxygen saturation
Time Frame: At the beginning of early rehabilitation
Oxygen saturation in sitting and standing positions.
At the beginning of early rehabilitation
30 seconds sit-to-stand test
Time Frame: At the beginning of early rehabilitation
To measure the strength of the lower limbs.
At the beginning of early rehabilitation
Change in 1 minute sit-to-stand test between two time points
Time Frame: Month 3, Month 6
To measure the strength of the lower limbs.
Month 3, Month 6
Change in Short form health survey between three time points
Time Frame: At the beginning of early rehabilitation, Month 3, Month 6
Is a general health questionnaire for the assessment of the patient's quality of life. Two summary scores are reported: a mental component score and a physical component score. The scores may be reported as Z-scores.
At the beginning of early rehabilitation, Month 3, Month 6
2-minute walking test
Time Frame: At the beginning of early rehabilitation
For mobility assessment
At the beginning of early rehabilitation
Change in 6-minute walking test between two time points
Time Frame: Month 3, Month 6
For mobility assessment
Month 3, Month 6
Change in Functional Independence Measure Scale between two time points
Time Frame: At the beginning of early rehabilitation, Month 3
Evaluate the functional autonomy of the patient both on the motor and cognitive side (minumum score:18 maximum score:126 ). At 3 months the "FIM efficiency" is evaluated as a measure of the efficiency of the rehabilitation intervention.
At the beginning of early rehabilitation, Month 3
Change in Montreal Cognitive Assessment (MoCA) between two time points
Time Frame: Month 3, Month 6
Cognitive screening test. Higher scores (0-30) are related to a better performance.
Month 3, Month 6
Cognitive Reserve Index questionnaire
Time Frame: Month 3
For measuring cognitive reserve. It comprehends a overall evaluation of the subject's cognitive status based on social and personal data. Higher scores underline major cognitive reserves.
Month 3
Change in Patient Health Questionnaire-9 (PHQ-9) between two time points
Time Frame: Month 3, Month 6
To identify the presence of depression and measure its severity. Score goes from 0 to 27 in which higer numbers represent worse clinical outcomes.
Month 3, Month 6
Change in Beck Anxiety Inventory (BAI) between two time points
Time Frame: Month 3, Month 6
To measure the severity of anxiety. Higher scores (0-63) indicates more severe anxiety symptoms
Month 3, Month 6
Change in Connor-Davidson Resilience Scale between two time points
Time Frame: Month 3, Month 6
To measure the resilience. Total score goes from 0 to 40, higher points mean greater resilience.
Month 3, Month 6
Change in Impact of Event Scale - Revised between two time points
Time Frame: Month 3, Month 6
To measure the amount of distress that associate with a specific event. Total score varies from 0 to 88, higher scores indicate greater post-event distress.
Month 3, Month 6
Change in General Self Efficacy Scale between two time points
Time Frame: Month 3, Month 6
To assess how much people believe they can achieve their goals, despite difficulties. Total score could be from 4 to 40, higher results show larger self efficacy perception.
Month 3, Month 6
Change in Pittsburgh Sleep Quality Index (PSQI) between two time points
Time Frame: Month 3, Month 6
To assess sleep quality. Higher scores are related to a worse sleep quality.
Month 3, Month 6
Covid19 Yorkshire Rehabilitation Scale (C19-YRS)
Time Frame: Referred changes between 3, 6 and 12 months after the symtomps onset
Clinical interview (qualitative evaluation) for investigating perceived outcomes after the acute phase of the pathology.
Referred changes between 3, 6 and 12 months after the symtomps onset
Changes on pain intensity assessed with a Numeric Rating Scale (NRS) between three time points
Time Frame: Month 3, Month 6, Month 12
To estimate the amount of pain perceived through a numerical classification in which higher scores indicate greater pain intensity
Month 3, Month 6, Month 12
Changes in Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) score between three time points
Time Frame: Month 3, Month 6, Month 12
To investigate neuropathic charateristics of pain. The global score goes from 0 to 24, over 12 points it is palusible the presence of neuropathic mechanism.
Month 3, Month 6, Month 12
Changes in Central Sensitization Inventory (CSI) score between three time points
Time Frame: Month 3, Month 6, Month 12
To detect the presence of central sensitization (score between 0-100 in which higher scores suggest the presence of central sensitization)
Month 3, Month 6, Month 12
Pressure Pain Threshold (PPT)
Time Frame: Month 3, Month 6, Month 12
Changes assessed with an algometer on upper trapezius and rectus femoris bilaterally
Month 3, Month 6, Month 12
Temporal Summation (TS)
Time Frame: Month 3, Month 6, Month 12
Changes assessed with an algometer on upper trapezius and rectus femoris bilaterally
Month 3, Month 6, Month 12
Changes in Pain Catastrophizing Scale (PCS) score between three time points
Time Frame: Month 3, Month 6, Month 12
To examine the pain experience felt
Month 3, Month 6, Month 12
Changes in Tampa Scale of Kinesiophobia (TSK) score between three time points
Time Frame: Month 3, Month 6, Month 12
For detecting the pain consequences on movement and related beliefs
Month 3, Month 6, Month 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2020

Primary Completion (Anticipated)

June 30, 2023

Study Completion (Anticipated)

November 30, 2023

Study Registration Dates

First Submitted

October 29, 2020

First Submitted That Met QC Criteria

November 2, 2020

First Posted (Actual)

November 4, 2020

Study Record Updates

Last Update Posted (Estimate)

January 13, 2023

Last Update Submitted That Met QC Criteria

January 11, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Early rehabilitation

3
Subscribe